Fibromyalgia and Pramipexole: Promise and Precaution [8]

Journal of Rheumatology

Volumn 30, Issue 12, 2003, Pages 2733-

  Holman, Andrew J ^a   Fam, Adel G ^b  

^a Pacific Rheumatology Associates   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLONAZEPAM; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; LORAZEPAM; PRAMIPEXOLE; PROTON PUMP INHIBITOR; RECEPTOR SUBTYPE;

BINDING AFFINITY; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SAFETY; FIBROMYALGIA; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; NAUSEA; PARKINSON DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

BENZOTHIAZOLES; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROMYALGIA; HUMANS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; THIAZOLES; TREATMENT OUTCOME;

EID: 0348109360     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
2. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975;37:341-51.
3. Yunus M, Aldag J. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ 1996;312:1339.
4. Saletu M, Anderer P, Saletu-Zyhlarz G, et al. Restless legs syndrome and periodic limb movement: acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol 2001;11:153-61.
5. Holman AJ. Effect of lorazepam on pain score for refractory fibromyalgia [abstract]. Arthritis Rheum 1998;41 Suppl:A1359.
6. Holman AJ. Safety and efficacy of lorazepam for fibromyalgia after one year [abstract]. Arthritis Rheum 1999;42 Suppl:A487.
7. Lin SC, Kaplan J, Burger CD, Fredrickson PA. Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc 1998;73:497-500.
8. Holman AJ. Safety and efficacy of the dopamine agonist, pramipexole, on pain score for refractory fibromyalgia [abstract]. Arthritis Rheum 2000;43 Suppl:A1599.
9. Holman AJ. Ropinirole, a dopamine agonist, for refractory fibromyalgia: preliminary observations [letter]. J Clin Rheumatol 2003;9:277-9.